Marqeta's 2026 Growth Slowdown Priced In—Can It Execute the "Buy the Dip" Trade?

The market's reaction to Marqeta's fourth-quarter results was a textbook case of "sell the news." The company delivered a solid beat on the top line, but the stock fell sharply, signaling the positive surprise was already priced in.

Revenue came in at $172.1 million, a 3% beat against analyst estimates. The GAAP EPS also edged out expectations, with a loss of $0 per share versus the anticipated $0.01 loss. More importantly, the company posted a record total processing volume (TPV) of $109 billion, representing a robust 36% year-over-year growth. This operational metric underscores the underlying strength of the platform, showing a massive increase in the dollar value of transactions flowing through its system.

Yet, despite these positive numbers, shares dropped 7.5% on the news. The classic explanation is that the beat was anticipated. The market had already built the strong revenue growth and TPV milestone into the stock price. When the actual print arrived, it met but did not exceed the whisper number, leading to a relief rally that quickly turned into a profit-taking selloff.

The setup was complete. The beat was priced in, and the subsequent guidance reset-projecting next quarter's revenue to be roughly in line with expectations-provided the catalyst for the negative reaction. The expectation gap had closed, leaving investors to reassess the forward trajectory.

The Guidance Reset: Slowing Growth Priced In?

Management's 2026 outlook frames the core expectation gap. The company now guides for net revenue growth of 12% to 14% and gross profit growth of 10% to 12%. That is a clear deceleration from the 27% and 22% growth seen in the just-completed fourth quarter of 2025. The shift is not a surprise, however, as it follows a prior revision to its 2025 net revenue outlook downward due to accounting impacts from a renegotiated partnership.

The market's reaction suggests this slowdown was already priced in. Shares have been under pressure for months, with a 90-day return of negative 15.35% prior to the earnings release. This prolonged decline indicates investors had already discounted a more moderate growth trajectory. The formal guidance, therefore, may not be the primary catalyst for the stock's post-earnings drop; it likely served as a confirmation of a narrative the market had been building for some time.

The question now is whether this is a genuine, structural deceleration or a necessary recalibration. The guidance reset follows a period of exceptional growth, and the new targets are still in the double-digit range, which is robust for a company of Marqeta's scale. The bear case, however, points to vulnerabilities like customer concentration and tougher comparisons in key verticals, which could pressure execution against these new, slower targets. The stock's recent weakness shows the market is skeptical about the durability of the high-growth story, making the 2026 outlook a critical test of whether the company can manage expectations without a full-blown disappointment.

Valuation and the Growth Narrative: Is the Multiple Right?

The market is now squarely in the "expectations vs. reality" phase for Marqeta. The stock trades at a market cap of $1.83 billion, a valuation that must now support a slower growth path. The analyst consensus is neutral, with a mix of Buy, Hold, and Sell ratings, indicating deep division on whether the company can navigate its new, lower-growth trajectory. The median price target sits at $5.50, implying a 34.5% upside from recent levels. Yet, this optimism is tempered by the fact that the most recent analyst downgrades have been from firms like Mizuho and Goldman Sachs, suggesting the bear case is gaining ground.

This tension is visible in the price action. The stock has shown short-term resilience, with a 7-day price momentum of +4.88%. That dip-buying momentum contrasts sharply with a 90-day return of negative 15.35% and a 1-year total return of -13.9%. In other words, the market is seeing a classic "buy the dip" dynamic from traders focused on the near term, while the longer-term narrative remains under pressure. The valuation multiple itself is a key battleground. Marqeta's trailing sales multiple sits at 2.8x, which is above both its industry peer average of 1.7x and the broader financial sector. This premium suggests investors are still pricing in future growth and margin expansion, even as the near-term growth rate decelerates.

The bottom line is that the current price reflects a high-stakes bet. It assumes Marqeta can successfully manage its customer concentration, defend margins against competition, and scale its new European capabilities to justify a rich multiple. If the company executes flawlessly against its 2026 guidance, the upside could be significant. But if the growth slowdown proves more persistent than expected, or if the costs of expansion pressure profitability, the valuation multiple could compress. For now, the market is giving the company the benefit of the doubt, but the expectation gap has shifted from a high-growth beat to a test of execution against a slower, steadier path.

Catalysts and Risks: What to Watch for the Next Expectation Gap

The stock's new equilibrium will be determined by a handful of near-term events that will test the new, slower growth narrative. The first major test arrives with the Q1 2026 results, where the company is guiding for revenue of $164.1 million at the midpoint. This is a clear deceleration from the 26.7% year-over-year growth seen in the prior quarter. The market will be watching for execution against this guidance. A beat here would signal the company is managing the slowdown smoothly. A miss, however, would confirm the bear case that growth is stalling faster than anticipated, likely pressuring the stock further.

A second key risk to monitor is customer concentration, particularly within the Buy Now Pay Later (BNPL) vertical. Analysts have noted concerns about potential deceleration in growth from key clients in this segment. Any update suggesting these large partnerships are scaling more slowly than expected would directly challenge the sustainability of the 2026 growth targets. The market has already priced in a slowdown, but it needs to see evidence that the company can diversify its base and mitigate this vulnerability.

Finally, investors must watch for any dilution overhang. In February, Marqeta filed a $106 million shelf registration for 25.9 million Class A shares tied to an employee stock plan. While this is a routine filing for equity compensation, it represents a potential future supply of shares. Any movement on this registration or an accelerated issuance could act as a headwind to the stock, adding pressure to the valuation multiple that already demands flawless execution.

The bottom line is that Marqeta's path forward is now defined by these specific catalysts and risks. The stock's recent dip-buying momentum shows traders are looking for a near-term bounce, but the longer-term trajectory hinges on how well the company navigates this new, lower-growth reality. The next expectation gap will open when the company either meets, beats, or disappoints on these concrete tests.